Evidence map›Paper›PMID 32938674›Full record

ArticleScience advances2020

Polysaccharide length affects mycobacterial cell shape and antibiotic susceptibility.

Alexander M Justen, Heather L Hodges, Lili M Kim, Patric W Sadecki, Sara Porfirio, Eveline Ultee, Ian Black, Grace S Chung, Ariane Briegel, Parastoo Azadi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Frontiers in immunology · 2023
    Review
  6. AuClOrganic letters · 2022
    Article
  7. Article
  8. An ABC transporter Wzm-Wzt catalyzes translocation of lipid-linked galactan across the plasma membrane in mycobacteria.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Alexander M JustenDepartment of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA 02139, USA.ORCID 0000-0003-3702-7648
Heather L HodgesDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, WI 53706-1322, USA.ORCID 0000-0002-5929-2672
Lili M KimDepartment of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706-1544, USA.ORCID 0000-0003-3875-2542
Patric W SadeckiDepartment of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, WI 53706-1322, USA.
Sara PorfirioComplex Carbohydrate Research Center, 315 Riverbend Rd, Athens, GA 30602, USA.ORCID 0000-0002-3972-4108
Eveline UlteeInstitute of Biology, University of Leiden, 2333 BE Leiden, Netherlands.ORCID 0000-0002-0237-6058
Ian BlackComplex Carbohydrate Research Center, 315 Riverbend Rd, Athens, GA 30602, USA.
Grace S ChungDepartment of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706-1544, USA.
Ariane BriegelInstitute of Biology, University of Leiden, 2333 BE Leiden, Netherlands.ORCID 0000-0003-3733-3725
Parastoo AzadiComplex Carbohydrate Research Center, 315 Riverbend Rd, Athens, GA 30602, USA.
Laura L KiesslingDepartment of Chemistry, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, MA 02139, USA. kiesslin@mit.edu.ORCID 0000-0001-6829-1500
University of Wisconsin–Madison · USLeiden University · NLBroad Institute · US

Funding

BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Chemistry-Biology Interface Training ProgramT32GM008505 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BLACKWELL, HELEN E. · 1993 to 2023
$9.8M
The Chemistry and Biology of Galactofuranose-Containing GlycansR01AI126592 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Laura L Kiessling · 2017 to 2026
$5.2M
Chemoenzymatic synthesis of bacterial polysaccharidesU01GM125288 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KIESSLING, LAURA L, LI, LEI · 2017 to 2020
$3.1M
MALDI TOF/TOF Mass SpectrometerS10RR024601 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI GELLMAN, SAMUEL H. · 2008 to 2008
$376k
Chemical Biology Tools for Visualization of Bacterial Chemoreceptor SignalingF31GM108408 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI HODGES, HEATHER L · 2014 to 2015
$60k
NCRR NIH HHS S10 RR024601NIAID NIH HHS R01 AI126592NIGMS NIH HHS F31 GM108408NIGMS NIH HHS T32 GM008349NIGMS NIH HHS T32 GM008505NIGMS NIH HHS U01 GM125288
6 · The paper itself

Abstract

Bacteria control the length of their polysaccharides, which can control cell viability, physiology, virulence, and immune evasion. Polysaccharide chain length affects immunomodulation, but its impact on bacterial physiology and antibiotic susceptibility was unclear. We probed the consequences of truncating the mycobacterial galactan, an essential linear polysaccharide of about 30 residues. Galactan covalently bridges cell envelope layers, with the outermost cell wall linkage point occurring at residue 12. Reducing galactan chain length by approximately half compromises fitness, alters cell morphology, and increases the potency of hydrophobic antibiotics. Systematic variation of the galactan chain length revealed that it determines periplasm size. Thus, glycan chain length can directly affect cellular physiology and antibiotic activity, and mycobacterial glycans, not proteins, regulate periplasm size.

Indexed as

MycobacteriumPolysaccharidesAnti-Bacterial AgentsCell ShapeGalactansAnti-Bacterial AgentsGalactansPolysaccharides

Identifiers

PMID32938674
PMCPMC7494350
OpenAlexW3087641419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.